Phoenixin 20 ameliorates pulmonary arterial hypertension via inhibiting inflammation and oxidative stress
Aging · 2024
DOI: 10.18632/aging.205468 ↗Kurz gefasst
Fachartikel in der Zeitschrift Aging, 2024. Verfasst von Yaqin Chai und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pulmonary and Critical Care Medicine, Xi’an Chest Hospital, Xi’an 710100, China. Hauptthemen laut MEDLINE: Pulmonary Arterial Hypertension, Hypertension, Pulmonary, Peptide Hormones. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pulmonary and Critical Care Medicine, Xi’an Chest Hospital, Xi’an 710100, China.
- Department of Pulmonary and Critical Care Medicine, Xi’an International Medical Center Hospital, Xi’an 710100, China.
Zitieren
APA
Chai, Y., Gu, X., Zhang, H., Xu, X., & Chen, L. (2024). Phoenixin 20 ameliorates pulmonary arterial hypertension via inhibiting inflammation and oxidative stress. Aging. https://doi.org/10.18632/aging.205468
Vancouver
Chai Y, Gu X, Zhang H, Xu X, Chen L. Phoenixin 20 ameliorates pulmonary arterial hypertension via inhibiting inflammation and oxidative stress. Aging. 2024. doi:10.18632/aging.205468
BibTeX
@article{Chai2024,
author = {Chai, Yaqin and Gu, Xing and Zhang, HongJun and Xu, Xinting and Chen, Lizhan},
title = {Phoenixin 20 ameliorates pulmonary arterial hypertension via inhibiting inflammation and oxidative stress},
journal = {Aging},
year = {2024},
doi = {10.18632/aging.205468}
}
EUVIMED